electroCore宣布首名患者加入Gammacore™非侵入性迷走神经刺激治疗创伤后应激障碍研究者发起研究

美股速递
Apr 07

生物电医学领域创新企业electroCore宣布,其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效,标志着公司在拓展神经系统疾病治疗边界方面取得新进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10